IHS Chemical Week

EnviroTech :: Biotech

Abbott Completes Acquisition of Facet Biotech

10:18 PM MDT | April 21, 2010 | Deepti Ramesh

Abbott Laboratories (Abbott Park, IL) says it has completed the previously announced acquisition of biotechnology company Facet Biotech (Redwood City, CA), for a total transaction value of about $450 million. The acquisition provides Abbott with a promising biologic intended to treat multiple sclerosis and compounds that complement its existing diverse oncology program. “Facet's depth of biologics experience and sophisticated antibody engineering platforms complement Abbott's current R&D programs in oncology, immunology and other therapeutic...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa